Back to search

National and Kapodistrian University of Athens

Ανίχνευση μοριακών διαταραχών σε γυναίκες με πρώιμη ωοθηκική ανεπάρκεια

Abstract

dc:description

Background: The etiology of premature ovarian insufficiency (POI) is multifactorial and may include genetic and/or environmental factors. Nevertheless, the etiology remains unknown in 90% of the cases, which are classified as idiopathic. Although in ~30% of women with POI the disease has a familiar pattern, in only ~7% a molecular defect has been identified.Αim of the study: The aim of the study was to search for genetic defects in genes related to the development and/or function of the ovary and are linked to POI: FOXL2, BMP15, GDF9, FOXE1 and NOBOX. We hypothesized that causative molecular defects could be identified more frequently in cases with early onset of POI and that analysis of multiple genes in the same population sample could disclose existence of more than one molecular aberration in the same patient.Subjects and Methods: 38 subjects with onset of POI at an early age (mean age 17.4 ± 6.6 years) were included in the study. Bidirectional sequencing of the coding region of FOXL2, FOXE1, BMP15, NOBOX and GDF9 genes was performed. In addition, MLPA was applied in cases in which deletion and/or duplication needed to be excluded. Fifty female subjects from the general Greek population served as controls for the genes FOXL2, BMP15 and NOBOX, and seventy five for the gene FOXE1.Validation of results: The validation of the results was performed by in silico analysis, ab initio 3D protein modeling and by comparing the frequency of the identified genetic variants between patients with POI and controls from the Greek population, as well as, between patients and subjects of the European population of the 1000 Genome Project (1000 GP). Results: In the FOXL2 gene, a novel, de novo, heterozygous deletion (p.K150Rfs*121) was detected in one subject (2.6%). In the FOXE1 gene, a novel aberrant alanine tract was detected with genotype 8/16 in two patients and genotype 8/14 in one patient (normal genotypes: 14/14 or 16/16). Three more patients with aberrant alanine tract were detected with genotypes 12/16, 15/16 and 14/17, respectively. In the control group one individual had a FOXE1 alanine tract with a genotype of 8/14. In the BMP15 gene, the mutation p.Q115H/WT was detected in one subject, in none of our controls or the 1000 GP population. In silico analysis predicted that the mutation p.Q115H was damaging in 5/8 programmes. The mutation p.A180T/WT of the BMP15 gene was detected in 2.6% of the patients, 0% of our control group and 0.5% of the 1000 GP population. In silico analysis predicted that the variant p.A180T was damaging in 2/8 programmes. However, ab initio protein modeling predicted that the p.A180T disrupted the 3D structure of the corresponding BMP15 protein. The genotype c.-9C>G + p.N103S of the BMP15 gene was detected in homozygosity in 5.2% of the patients, 0% of our controls and 0.5% of the 1000 GP population (p: 0.075). All the identified variants in the NOBOX gene were classified as polymorphisms. No missense variants were detected in the GDF9 gene. In five patients, molecular aberrations in two genes in the same subject were identified.Conclusions: Genetic variants in five genes were searched for in patients with relatively early onset of ovarian insufficiency (mean age 17.4 ± 6.6 years). The percentage of genetic variants identified, as possibly related, to the phenotype in our patients with POI was much higher than previously reported (44.7% vs. 7%). The increased incidence of molecular defects in our POI group could be attributed to the younger age of POI onset in our group and the analysis of multiple genes in the same population sample. The existence of genetic aberrations in two genes in five subjects with POI, possibly indicates digenic inheritance, a phenomenon already described in other nosologic entities. The early recognition of genetic defects in women with POI has not only theoretical but also practical interest. The precise etiology of POI can determine more accurately the prognosis, guide the genetic counseling and facilitate planning fertility strategies (cryopreservation).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Settas, Nikolaos
  • Σέττας, Νικόλαος

Subjects

dc:subject × 7

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36114

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Settas, Nikolaos; Σέττας, Νικόλαος. Ανίχνευση μοριακών διαταραχών σε γυναίκες με πρώιμη ωοθηκική ανεπάρκεια. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36114